DNA Sequencing to Detect Residual Disease in Adults With Acute Myeloid Leukemia Prior to Hematopoietic Cell TransplantLaura W. Dillon, Christopher S. Hourigan, Alan Howard et al.|JAMA|2023Cited by 147
Measurable Residual <i>FLT3</i> Internal Tandem Duplication Before Allogeneic Transplant for Acute Myeloid LeukemiaLaura W. Dillon, Christopher S. Hourigan, Gege Gui et al.|JAMA Oncology|2024Cited by 58
Pre-MEASURE: Multicenter evaluation of the prognostic significance of measurable residual disease testing prior to allogeneic transplantation for adult patients with AML in first remission.Chris S. Hourigan, Kristin Page, Laura W. Dillon et al.|Journal of Clinical Oncology|2022Cited by 11
Measurable Residual <i>IDH1</i> before Allogeneic Transplant for Acute Myeloid LeukemiaGege Gui, Christopher S. Hourigan, Laura W. Dillon et al.|medRxiv|2023Cited by 2
Pre-MEASURE: <i>FLT3</i> -ITD and mutated <i>NPM1</i> measurable residual disease before allogeneic transplant in adults with AML in first remissionLaura W. Dillon, Christopher S. Hourigan, Gege Gui et al.|medRxiv|2022Cited by 1